| US20030114410A1 (en) | 2000-08-08 | 2003-06-19 | Technion Research And Development Foundation Ltd. | Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis |
| WO2003054141A2 (en)* | 2001-10-22 | 2003-07-03 | Children's Medical Center Corporation | Sperm-specific cation channel, catsper2, and uses therefor |
| AU2003243151A1 (en)* | 2002-08-16 | 2004-03-03 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
| EP1581641A4 (en)* | 2002-12-06 | 2006-11-15 | Diadexus Inc | Compositions, splice variants and methods relating to ovarian specific genes and proteins |
| US8871709B2 (en)* | 2003-02-05 | 2014-10-28 | Queensland University of Technolgy | Synthetic chimeric proteins comprising epidermal growth factor and vitronectin |
| WO2004090097A2 (en) | 2003-04-03 | 2004-10-21 | Bristol-Myers Squibb Company | Polynucleotide encoding a novel human p2x7 splice variant, hbmyp2x7v |
| WO2004094623A2 (en)* | 2003-04-04 | 2004-11-04 | Incyte Corporation | Cell adhesion and extracellular matrix proteins |
| EP2332982A1 (en)* | 2003-05-14 | 2011-06-15 | Sumitomo Chemical Co., Ltd. | Liver X receptor alpha splicing mutant protein, gene thereof and utilization of the same |
| MXPA06001329A (en)* | 2003-08-18 | 2006-05-04 | Wyeth Corp | NOVEL HUMAN LXRalpha VARIANTS. |
| WO2005046454A2 (en)* | 2003-11-12 | 2005-05-26 | Trustrees Of The University Of Pennsylvania | Methods of using gelsolin to treat or prevent bacterial sepsis |
| US9408891B2 (en) | 2003-11-12 | 2016-08-09 | The Trustees Of The University Of Pennsylvania | Methods of using gelsolin to treat or prevent bacterial sepsis |
| ATE510020T1 (en)* | 2003-12-24 | 2011-06-15 | G2 Inflammation Pty Ltd | TRANSGENIC NON-HUMAN MAMMAL WITH A POLYNUCLEOTIDE CODING FOR HUMAN-C5AR OR HUMANIZED C5AR |
| WO2005076012A2 (en)* | 2004-01-30 | 2005-08-18 | Five Prime Therapeutics, Inc. | Novel splice variants and methods of use thereof |
| US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
| US8124730B1 (en) | 2004-04-02 | 2012-02-28 | Bristol-Myers Squibb Company | Polynucleotide encoding a novel human P2X7 splice variant, HBMYP2X7v |
| EP1586587A1 (en)* | 2004-04-16 | 2005-10-19 | Exonhit Therapeutics SA | Compositions and methods for detecting angiogenesis |
| CA2607686C (en) | 2004-05-12 | 2014-11-04 | Thomas P. Stossel | Use of gelsolin to treat infections |
| US20090004193A1 (en)* | 2004-07-23 | 2009-01-01 | Bayer Healthcare Ag | Diagnostics and Therapeutics for Diseases Associated With Vasoactive Intestinal Peptide Receptor 1 (Vpac1) |
| WO2006008008A2 (en)* | 2004-07-23 | 2006-01-26 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with hepatocyte nuclear factor 4, alpha (hnf4a) |
| EP1802749B1 (en)* | 2004-10-21 | 2012-08-22 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Kaspp (lrrk2) gene, its production and use for the detection and treatment of neurodegenerative disorders |
| EP2275547B1 (en) | 2004-12-13 | 2014-03-05 | Alethia Biotherapeutics Inc. | Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| KR100664587B1 (en)* | 2004-12-22 | 2007-01-04 | 김현기 | Human cancer suppressor gene, protein encoded thereby, expression vector comprising the same and cells transformed with the vector |
| WO2006128902A1 (en) | 2005-06-01 | 2006-12-07 | Evotec Neurosciences Gmbh | Diagnostic and therapeutic target slc39a12 proteins for neurodegenerative diseases |
| EP1739092A1 (en)* | 2005-06-28 | 2007-01-03 | I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale | Peptidic antagonists of class III semaphorins/neuropilins complexes |
| CA2814598A1 (en) | 2005-09-12 | 2007-03-22 | The Regents Of The University Of Michigan | Recurrent gene fusions in prostate cancer |
| US9957569B2 (en) | 2005-09-12 | 2018-05-01 | The Regents Of The University Of Michigan | Recurrent gene fusions in prostate cancer |
| AU2014265023A1 (en)* | 2005-12-20 | 2014-12-04 | Sbi Biotech Co, Ltd. | Anti-ILT7 Antibody |
| AU2012244391B2 (en)* | 2005-12-20 | 2014-09-11 | Sbi Biotech Co., Ltd. | Anti-ILT7 antibody |
| HRP20130494T1 (en)* | 2005-12-20 | 2013-08-31 | Sbi Biotech Co., Ltd. | Anti-ilt7 antibody |
| EP3936621A1 (en)* | 2006-01-20 | 2022-01-12 | Cell Signaling Technology, Inc. | Translocation and mutant ros kinase in human non-small cell lung carcinoma |
| US8383799B2 (en) | 2006-01-20 | 2013-02-26 | Cell Signaling Technology, Inc. | Translocation and mutant ROS kinase in human non-small cell lung carcinoma |
| WO2007089659A2 (en)* | 2006-01-26 | 2007-08-09 | Caprion Pharmaceutical, Inc. | Tat-039 and methods of assessing and treating cancer |
| WO2007089783A2 (en)* | 2006-01-30 | 2007-08-09 | Caprion Pharmaceuticals, Inc. | Tat-044 and methods of assessing and treating cancer |
| WO2007089793A2 (en)* | 2006-01-31 | 2007-08-09 | Caprion Pharmaceuticals, Inc. | Tat-041 and methods of assessing and treating cancer |
| CA2680333C (en) | 2006-03-15 | 2016-10-25 | The Brigham And Women's Hospital, Inc. | Use of gelsolin to treat multiple sclerosis and to diagnose neurologic diseases |
| JP5322917B2 (en) | 2006-03-15 | 2013-10-23 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド | Use of gelsolin for the diagnosis and treatment of inflammatory diseases |
| US7452985B2 (en) | 2006-08-17 | 2008-11-18 | Visgeneer, Inc. | Human Ron-related gene variant associated with cancers |
| US9513296B2 (en) | 2006-08-21 | 2016-12-06 | Eidgenoessische Technische Hochschule Zurich | Specific and high affinity binding proteins comprising modified SH3 domains of Fyn kinase |
| EP1892248A1 (en)* | 2006-08-21 | 2008-02-27 | Eidgenössische Technische Hochschule Zürich | Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinase |
| US9689879B2 (en) | 2006-08-21 | 2017-06-27 | Eidgenoessische Technische Hochschule Zurich | Specific and high affinity binding proteins comprising modified SH3 domains of Fyn kinase |
| WO2008042814A2 (en)* | 2006-09-29 | 2008-04-10 | California Institute Of Technology | Mart-1 t cell receptors |
| EP2094307A4 (en) | 2006-11-08 | 2015-08-26 | Macrogenics West Inc | Tes7 and antibodies that bind thereto |
| CA2692793C (en) | 2007-07-06 | 2014-05-20 | The Regents Of The University Of Michigan | Mipol1-etv1 gene rearrangements |
| ES2534490T3 (en) | 2007-08-02 | 2015-04-23 | Gilead Biologics, Inc. | LOX and LOXL2 inhibitors and uses thereof |
| WO2009020521A2 (en) | 2007-08-03 | 2009-02-12 | The Brigham And Women's Hospital, Inc. | Identification and treatment of estrogen responsive prostate tumors |
| US7892760B2 (en) | 2007-11-19 | 2011-02-22 | Celera Corporation | Lung cancer markers, and uses thereof |
| CA2711691A1 (en)* | 2008-01-07 | 2009-07-16 | Patrys Limited | Barb4 target, antibody designated barb4, barb4 related antibodies, and methods of making and using same |
| PT2708603T (en) | 2008-01-25 | 2017-07-20 | The Brigham And Women`S Hospital Inc | Diagnostic and therapeutic uses of gelsolin in renal failure |
| WO2009131605A2 (en)* | 2008-01-28 | 2009-10-29 | Thomas Jefferson University | Fusion partner cell line for preparation of hybrid cells expressing human antibodies |
| EP2322610B1 (en) | 2008-07-16 | 2016-12-14 | Medical and Biological Laboratories Co., Ltd. | Anti-human clcp1 antibody and use thereof |
| AU2013202393B2 (en)* | 2008-07-16 | 2015-01-22 | Institute For Research In Biomedicine | Human cytomegalovirus nuetralizing antibodies and use thereof |
| WO2010033294A1 (en) | 2008-09-22 | 2010-03-25 | Cedars-Sinai Medical Center | Short-form human md-2 as a negative regulator of toll-like receptor 4 signaling |
| US9512196B2 (en) | 2008-09-22 | 2016-12-06 | Cedars-Sinai Medical Center | Short-form human MD-2 as a negative regulator of toll-like receptor 4 signaling |
| CA2751161C (en)* | 2008-12-30 | 2018-10-02 | Children's Medical Center Corporation | Method of predicting acute appendicitis |
| WO2010080769A2 (en) | 2009-01-06 | 2010-07-15 | Arresto Biosciences, Inc. | Chemotherapeutic methods and compositions |
| AU2010226726B8 (en) | 2009-03-16 | 2014-08-14 | Pangu Biopharma Limited | Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities |
| JP4495776B1 (en)* | 2009-07-30 | 2010-07-07 | 日本製薬株式会社 | Fusion protein |
| AU2010284036B2 (en) | 2009-08-21 | 2014-12-18 | Gilead Biologics, Inc. | Catalytic domains from lysyl oxidase and LOXL2 |
| EP2478120B1 (en) | 2009-09-17 | 2015-09-02 | The Regents Of The University Of Michigan | Recurrent gene fusions in prostate cancer |
| CA2781887C (en) | 2009-11-30 | 2018-03-27 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| UA109888C2 (en) | 2009-12-07 | 2015-10-26 | | ANTIBODY OR ANTIBODILITY ANTIBODY OR ITS BINDING TO THE β-CLOTE, FGF RECEPTORS AND THEIR COMPLEXES |
| US8828395B2 (en) | 2009-12-11 | 2014-09-09 | Atyr Pharma, Inc. | Antibodies that bind tyrosyl-tRNA synthetases |
| ES2535951T3 (en) | 2009-12-11 | 2015-05-19 | Atyr Pharma, Inc. | Histidyl tRNA synthetases to reduce inflammation |
| CN103154034B (en) | 2010-04-13 | 2016-06-08 | 塞尔德克斯医疗公司 | Antibodies that bind human cd27 and uses thereof |
| US8946157B2 (en)* | 2010-05-03 | 2015-02-03 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-tRNA synthetases |
| CA2804424C (en) | 2010-07-12 | 2021-03-30 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases |
| AU2011293294B2 (en) | 2010-08-25 | 2016-03-24 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Tyrosyl-tRNA synthetases |
| US20130303439A1 (en)* | 2010-09-30 | 2013-11-14 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Chimeric peptides including a penetrating peptide and a binding domain of pp2a catalytic subunit to caspase-9 |
| US8945556B2 (en) | 2010-11-19 | 2015-02-03 | The Regents Of The University Of Michigan | RAF gene fusions |
| US9714419B2 (en) | 2011-08-09 | 2017-07-25 | Atyr Pharma, Inc. | PEGylated tyrosyl-tRNA synthetase polypeptides |
| CA2852629A1 (en)* | 2011-10-26 | 2013-05-02 | Nuclea Biotechnologies, Inc. | Usp2a peptides and antibodies |
| WO2013123432A2 (en) | 2012-02-16 | 2013-08-22 | Atyr Pharma, Inc. | Histidyl-trna synthetases for treating autoimmune and inflammatory diseases |
| EP2845862B1 (en) | 2012-05-01 | 2018-11-21 | FUJIFILM Corporation | Method for incubating pluripotent stem cells and polypeptide to be used therefor |
| US10023640B2 (en)* | 2012-10-05 | 2018-07-17 | Kadmon Corporation, Llc | Human anti-VEGFR-2/KDR antibodies |
| AU2014236198A1 (en) | 2013-03-14 | 2015-10-15 | Bayer Healthcare Llc | Monoclonal antibodies against antithrombin beta complexed with heparin |
| AU2014233436B2 (en) | 2013-03-15 | 2019-12-05 | Atyr Pharma, Inc. | Histidyl-tRNA synthetase-Fc conjugates |
| JP6854246B2 (en) | 2015-06-08 | 2021-04-07 | アーケア ダイアグノスティクス リミテッド | How to analyze urine sample |
| WO2016198835A1 (en) | 2015-06-08 | 2016-12-15 | Arquer Diagnostics Limited | Methods and kits |
| WO2017024137A1 (en)* | 2015-08-04 | 2017-02-09 | New York University | Progranulin (pgrn) fragments and derivatives for treatment or alleviation of lysosomal storage diseases |
| US11072652B2 (en) | 2016-03-10 | 2021-07-27 | Viela Bio, Inc. | ILT7 binding molecules and methods of using the same |
| PE20240693A1 (en)* | 2016-04-08 | 2024-04-10 | Immunocore Ltd | T CELL RECEPTORS |
| US20240002459A1 (en)* | 2016-07-14 | 2024-01-04 | Emory University | Granulin Compositions and Uses Related Thereto |
| EP3612215B1 (en) | 2017-04-20 | 2024-08-28 | aTyr Pharma, Inc. | Compositions for treating lung inflammation |
| CA3062591A1 (en) | 2017-05-08 | 2018-11-15 | Gritstone Oncology, Inc. | Alphavirus neoantigen vectors |
| JP7348844B2 (en) | 2017-06-07 | 2023-09-21 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | Compositions and methods for internalizing enzymes |
| KR20250096876A (en)* | 2017-07-31 | 2025-06-27 | 리플렉션 바이오테크놀러지스 리미티드 | Cellular models of and therapies for ocular diseases |
| IL315325B1 (en) | 2018-01-04 | 2025-07-01 | Iconic Therapeutics Inc | Anti-tissue factor antibodies, antibody-drug conjugates, and related methods |
| US12258597B2 (en) | 2018-02-07 | 2025-03-25 | Regeneron Pharmaceuticals, Inc. | Methods and compositions for therapeutic protein delivery |
| GB201803010D0 (en)* | 2018-02-26 | 2018-04-11 | Royal Holloway & Bedford New College | Neurodegenerative disorders |
| SG11202010011RA (en) | 2018-04-17 | 2020-11-27 | Celldex Therapeutics Inc | Anti-cd27 and anti-pd-l1 antibodies and bispecific constructs |
| EP3793591A1 (en) | 2018-05-17 | 2021-03-24 | Regeneron Pharmaceuticals, Inc. | Anti-cd63 antibodies, conjugates, and uses thereof |
| IL317797A (en) | 2019-05-30 | 2025-02-01 | Gritstone Bio Inc | Modified adenoviruses |
| CN111859913B (en)* | 2020-06-12 | 2024-04-12 | 北京百度网讯科技有限公司 | Processing method and device of wind control characteristic factors, electronic equipment and storage medium |
| JP2023541108A (en) | 2020-08-06 | 2023-09-28 | グリットストーン バイオ インコーポレイテッド | Multi-epitope vaccine cassette |
| CA3213677A1 (en)* | 2021-03-30 | 2022-10-06 | Samir Hanash | Citrullinated proteins as biomarkers and therapy targets for cancer |
| AU2023326720A1 (en) | 2022-08-18 | 2025-04-03 | Immunocore Ltd | T cell receptor fusion proteins specific for mage a4 |
| WO2024163607A2 (en)* | 2023-02-02 | 2024-08-08 | Board Of Regents, The University Of Texas System | T-cell receptors targeting egfr and methods of use thereof |